• Health Care

AIM ImmunoTech Files Three Provisional Patent Applications Surrounding Ampligen(R) for Use Against the SARS-like Wuhan 2019 Novel Coronavirus

Accesswire, February 11, 2020 : (ACN Newswire) - AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional…